The trials, which Novo had previously called a “lottery ticket” to underline its highly uncertain outcome, were testing whether the medicine could slow cognitive decline in patients. The setback ...
Diagnoses of limbic-predominant age-related TDP-43 encephalopathy (LATE) dementia rose as awareness of the disorder increased. (New York Times) The New York Times also reviewed other forms of dementia ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results